The coronavirus pandemic has put a lot of our lab-based research on hold. But we don’t want to lose momentum or to let progress stall. We need your support, now more than ever, so that our researchers can make up for lost time.
‘We’re very proud that our researchers are doing everything they can to help overcome this crisis and to ensure that breast cancer research in the labs can continue as soon as possible.’ Dr Simon Vincent, Director of Research.
Read more about how Breast Cancer Now’s research has been affected by COVID-19.
Triple negative breast cancer is a sub-type of the disease for which there are currently no targeted treatments. In addition, this form of breast cancer can be more aggressive than others.
Triple negative breast cancer is a sub-type of the disease for which there are currently no targeted treatments. In addition, this form of breast cancer can be more aggressive than others.
Patients with hormone-positive breast cancer are usually treated with hormone therapies such as tamoxifen or aromatase inhibitors. However, many of these patient's breast camcer become resistant to these drugs or develop resistance during treatment, allowing their breast cancer to return.
